Skip to main content
. 2020 Mar 23;174(6):1–11. doi: 10.1001/jamapediatrics.2020.0052

Table 1. Characteristics of the Study Population by Expansion Status Before and After Expansion.

Characteristic No. (%) of participantsa
All (N = 21 069) EXP states NEXP states
Before expansion (n = 5387) After expansion (n = 7849) Before expansion (n = 3051) After expansion (n = 4782)
Age, y
<1 2071 (9.8) 531 (9.9) 701 (8.9) 330 (10.8) 509 (10.6)
1-4 7427 (35.3) 1930 (35.8) 2762 (35.2) 1083 (35.5) 1652 (34.5)
5-9 5463 (25.9) 1388 (25.8) 2091 (26.6) 770 (25.2) 1214 (25.4)
10-14 6108 (29.0) 1538 (28.6) 2295 (29.2) 868 (28.4) 1407 (29.4)
Race/ethnicity
Non-Hispanic white 10 185 (48.3) 2214 (41.1) 3114 (39.7) 1949 (63.9) 2908 (60.8)
Non-Hispanic other 1854 (8.8) 516 (9.6) 835 (10.6) 181 (5.9) 322 (6.7)
Non-Hispanic black 2317 (11.0) 371 (6.9) 527 (6.7) 553 (18.1) 866 (18.1)
Hispanic 6441 (30.6) 2230 (41.4) 3238 (41.3) 337 (11.0) 636 (13.3)
Missing 272 (1.3) 56 (1.0) 135 (1.7) 31 (1.0) 50 (1.0)
Sex
Male 11 265 (53.5) 2951 (54.8) 4157 (53.0) 1644 (53.9) 2513 (52.6)
Female 9804 (46.5) 2436 (45.2) 3692 (47.0) 1407 (46.1) 2269 (47.4)
Metropolitan area of residence
Nonmetropolitan 1871 (8.9) 106 (2.0) 170 (2.2) 623 (20.4) 972 (20.3)
Metropolitan 19 131 (90.8) 5281 (98.0) 7679 (97.8) 2405 (78.8) 3766 (78.8)
Missing 67 (0.3) 0 0 23 (0.8) 44 (0.9)
County educational levelb
High 4910 (23.3) 997 (18.5) 1528 (19.5) 926 (30.4) 1459 (30.5)
Middle to high 4923 (23.4) 1112 (20.6) 1556 (19.8) 894 (29.3) 1361 (28.5)
Middle to low 5232 (24.8) 1296 (24.1) 1888 (24.1) 780 (25.6) 1268 (26.5)
Low 5999 (28.5) 1982 (36.8) 2877 (36.7) 447 (14.7) 693 (14.5)
Missing 5 (0.02) 0 0 4 (0.1) 1 (0.02)
County poverty levelc
High 5086 (24.1) 1501 (27.9) 2212 (28.2) 536 (17.6) 837 (17.5)
Middle to high 5441 (25.8) 1499 (27.8) 2126 (27.1) 706 (23.1) 1110 (23.2)
Middle to low 4112 (19.5) 763 (14.2) 1153 (14.7) 847 (27.8) 1349 (28.2)
Low 6425 (30.5) 1624 (30.1) 2358 (30.0) 958 (31.4) 1485 (31.1)
Missing 5 (0.02) 0 0 4 (0.1) 1 (0.02)
Cancer site
Leukemias, myeloproliferative diseases, and myelodysplastic diseases 6797 (32.3) 1857 (34.5) 2714 (34.6) 874 (28.6) 1352 (28.3)
Lymphomas and reticuloendothelial 2180 (10.3) 554 (10.3) 772 (9.8) 328 (10.8) 526 (11.0)
CNS and miscellaneous intracranial and intraspinal 4289 (20.4) 1075 (20.0) 1504 (19.2) 701 (23.0) 1009 (21.1)
Neuroblastoma and other peripheral nervous cell 1438 (6.8) 346 (6.4) 487 (6.2) 237 (7.8) 368 (7.7)
Renal 1121 (5.3) 294 (5.5) 406 (5.2) 151 (4.9) 270 (5.6)
Retinoblastoma 586 (2.8) 125 (2.3) 238 (3.0) 101 (3.3) 122 (2.6)
Hepatic 389 (1.8) 97 (1.8) 147 (1.9) 44 (1.4) 101 (2.1)
Malignant bone 963 (4.6) 253 (4.7) 343 (4.4) 125 (4.1) 242 (5.1)
Soft-tissue and other extraosseous sarcomas 1449 (6.9) 361 (6.7) 517 (6.6) 230 (7.5) 341 (7.1)
Germ cell, trophoblastic, and gonads 730 (3.5) 193 (3.6) 250 (3.2) 110 (3.6) 177 (3.7)
Other malignant epithelial and malignant melanomas 1052 (5.0) 210 (3.9) 445 (5.7) 143 (4.7) 254 (5.3)
Other or unspecified 75 (0.4) 22 (0.4) 26 (0.3) 7 (0.2) 20 (0.4)
Insurance
Private or other 12 294 (58.4) 3528 (65.5) 4510 (57.5) 1736 (56.9) 2520 (52.7)
Medicaid 7728 (36.7) 1685 (31.3) 2982 (38.0) 1154 (37.8) 1907 (39.9)
Uninsured 325 (1.5) 81 (1.5) 95 (1.2) 50 (1.6) 99 (2.1)
Missing 722 (3.4) 93 (1.7) 262 (3.3) 111 (3.6) 256 (5.4)

Abbreviations: CNS, central nervous system; EXP, early expansion; NEXP, non–early expansion.

a

Percentages have been rounded and may not total 100.

b

Defined as percentage without high school educational attainment: less than 10.9% indicates high; 10.9% to 14.0%, middle to high; 14.1% to 20.7%, middle to low; and greater than 20.7%, as low.

c

Defined as percentage of families below poverty level: less than 7.65% indicates low; 7.65% to 10.14%, middle to low; 10.15% to 13.67%, middle to high; and greater than 13.67%, high.